Avidicure raises $50M in seed financing to advance its innovative antibody therapies, led by EQT Life Sciences with various partners.
Amount Raised
$50 Million
Round Type
Seed
LeidenBiotechnologyHealth CareTherapeuticsInvestors
Description
Avidicure, a biotechnology company based in Amsterdam, has successfully raised $50M in a seed financing round. The round was led by EQT Life Sciences, with participation from multiple investors including Kurma Partners and BioGeneration Ventures. The funds will support the development of Avidicure's multifunctional antibodies for oncology. Avidicure aims to enhance cancer treatment with its proprietary technology and lead product, AVC-S-101.
Quick answer
Avidicure raised $50 Million in a Seed round, dated April 27, 2025. Investors: Curie Capital, Bom, EQT Life Sciences, V Bio Ventures, BioGeneration Ventures and Kurma Partners. Avidicure is based in Leiden, South Holland, Netherlands.
- How much did Avidicure raise?
- Avidicure raised $50 Million in a Seed round on April 27, 2025.
- Who invested in Avidicure?
- Curie Capital, Bom, EQT Life Sciences, V Bio Ventures, BioGeneration Ventures and Kurma Partners are named as investors in this round.
- What does Avidicure do?
- Avidicure is a biotechnology company based in Amsterdam, The Netherlands, focused on pioneering a new multifunctional antibody modality for oncology.
- Where is Avidicure based and how big is it?
- Avidicure is based in Leiden, South Holland, Netherlands. Fundz records about 23 employees.
- Who are the decision-makers at Avidicure?
- Fundz holds 1 contact at Avidicure. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Avidicure that raised within 45 days of this round, from Fundz verified event records.
- Elkedonia raised $13M (Seed) on June 11, 2025.
- Mezzion Pharma raised $20M (Funding Round) on June 11, 2025.
- Synaptogenix raised $5.5M on June 9, 2025.
- Gradalis raised $13M on June 5, 2025.
- Aeon raised $9.3M (Seed) on June 4, 2025.
- TuHURA Biosciences raised $13M (Private Equity) on June 3, 2025.
Who to call at Avidicure, and when
A new round usually means Avidicure is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Avidicure raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Avidicure, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Avidicure. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Avidicure raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Avidicure raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.